Compare Nutrien Ltd (NTR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs Tempus AI — how do they compare? Nutrien Ltd trades at $67.28 (market cap $31.60B), while Tempus AI trades at $55.49 (market cap $9.93B). The key difference: Nutrien Ltd is far larger — about 3.2× Tempus AI's market cap, and Nutrien Ltd pays a 3.32% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| NTR | TEM | |
|---|---|---|
Market Cap | $31.60B | $9.93B |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $83.94 | $103.25 |
52-Week Low | $53.64 | $41.55 |
Enterprise Value | $43.40B | $10.56B |
Dividend Yield | 3.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutrien Ltd. (NTR) trades at $64.42, down 3.51% over 24 hours, with a bearish technical signal. The stock shows mixed earnings, missing Q2 2026 EPS estimates but beating in Q1. Fundamentals include a P/E of 13.04, net income margin of 8.44%, and a dividend of $0.55 per share. Recent news highlights strong potash sales and cost management, though input cost pressures persist.
The outlook is cautiously optimistic, supported by analyst consensus of $76.67 price target and 60.61% buy ratings. Key opportunities include structural gas advantages and agricultural cycle recovery, while risks involve volatile fertilizer demand and margin compression from higher costs.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
